NY S 7668
in committeeProhibits the sale of xylazine above a certain weight
New York · 2025-2026 Regular Session · upper
Description
Prohibits the knowing sale of xylazine above a certain weight to persons under the age of 21 and without proof of the intended use for institutional, veterinary, or scientific purposes.
- Introduced
- —
- Status date
- —
- Latest action
- 2026-01-07 — REFERRED TO CONSUMER PROTECTION
- Bill type
- bill
- Last updated
- —
Sponsors
- Nathalia Fernandezprimary
Committees
Not provided by source.
Action timeline
2025-04-28
REFERRED TO CONSUMER PROTECTION
referral-committee
2025-05-19
1ST REPORT CAL.1135
2025-05-20
2ND REPORT CAL.
2025-05-21
AMENDED 7668A
amendment-passage
2025-05-21
ADVANCED TO THIRD READING
2025-06-13
COMMITTED TO RULES
referral-committee
2026-01-07
REFERRED TO CONSUMER PROTECTION
referral-committee
Versions
Documents
- application/pdf(no extracted text yet)
- text/html(no extracted text yet)
- application/pdf
Votes
Consumer Protection Vote
2025-05-19 · pass · 6-0
Member-level votes (7)
- Siela Bynoe: yes
- Patricia Canzoneri-Fitzpatrick: yes
- Kristen Gonzalez: yes
- Rachel May: yes
- Christopher Ryan: yes
- William Weber: yes
- Zellnor Myrie: excused
Related bills
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:28:30.722574Z
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NY&identifier=S 7668. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
- Some documents have no extracted text yet, so version comparison may be limited.
See the methodology page for data sources and limitations.